ArticleGut and liver2021

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.

Joo Hye Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.